Myelodysplastic Syndrome--CDA-2 Hematological Improvement National Affirmation Study

Clinical trial NCT03335943 · UNKNOWN

Trial details

NCT number: NCT03335943
Sponsor: Chinese Society of Hematology
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)

Start date: 2017-12-01
Primary completion: 2019-12-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.